Adherence to treatment in a Western European paediatric population with haemophilia: Reliability and validity of the VERITAS-Pro scale

Haemophilia

Volumn 20, Issue 5, 2014, Pages 616-623

  Lock, J ^a   Raat, H ^b   Duncan, N ^c   Shapiro, A ^c   Beijlevelt, M ^d   Peters, M ^d   Tamminga, R Y J ^e   Leebeek, F W G ^b   Moll, H A ^a   Cnossen, M H ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Department of Haematology Indiana Haemophilia and Thrombosis Centre ^*  (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adherence; Children; Haemophilia; Reliability; Validated Haemophilia Regimen Treatment Adherence Scale Prophylaxis (VERITAS Pro); Validity

Indexed keywords

BLOOD CLOTTING FACTOR;

ADOLESCENT; CHILD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG SELF ADMINISTRATION; FEMALE; HEMOPHILIA A; HUMAN; INFANT; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; NETHERLANDS; PRESCHOOL CHILD; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VALIDATION STUDY;

ADOLESCENT; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEMOPHILIA A; HUMANS; INFANT; MALE; MEDICATION ADHERENCE; NETHERLANDS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF ADMINISTRATION; UNITED STATES;

EID: 84906769967     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12463     Document Type: Article

References (46)

1. Berntorp E. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens. Haemophilia 2009; 15: 1219-27.
2. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811.
3. World Health Organization YD. Adherence to Long-Term Therapies: Evidence for Action. Geneva: Switzerland, 2003: 211.
4. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996; 92: 973-8.
5. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
6. Royal S, Schramm W, Berntorp E et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
7. Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Diagnosis and management of haemophilia. BMJ 2012; 344: e2707.
8. Geraghty S, Dunkley T, Harrington C, Lindvall K, Maahs J, Sek J. Practice patterns in haemophilia A therapy - global progress towards optimal care. Haemophilia 2006; 12: 75-81.
9. De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia 2008; 14: 931-8.
10. du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia 2007; 13: 493-501.
11. Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia 2013; 19: 355-61.
12. Van den Berg HM, Dunn A, Fischer K, Blanchette VS. Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy. Haemophilia 2006; 12(Suppl 3): 159-68.
13. Teitel JM, Barnard D, Israels S, Lillicrap D, Poon MC, Sek J. Home management of haemophilia. Haemophilia 2004; 10: 118-33.
14. Ljung RC. Prophylactic treatment in Sweden-overtreatment or optimal model? Haemophilia 1998; 4: 409-12.
15. Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7: 392-6.
16. Khair K. Minimizing joint damage: the role of nurses in promoting adherence to hemophilia treatment. Orthop Nurs 2010; 29: 193-200; quiz 1-2.
17. Kyngas HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Health 2000; 26: 379-88.
18. Petrini P. Identifying and overcoming barriers to prophylaxis in the management of haemophilia. Haemophilia 2007; 13(Suppl 2): 16-22.
19. Thornburg CD. Physicians' perceptions of adherence to prophylactic clotting factor infusions. Haemophilia 2008; 14: 25-9.
20. Llewellyn C, Miners A, Lee C, Harrington C, Weinman J. The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment. Psychol Health 2003; 18: 185-200.
21. Collins PW, Bjorkman S, Fischer K et al. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost 2010; 8: 269-75.
22. Chan AK, Decker K, Warner M. Adherence with haemophilia treatments: a survey of haemophilia healthcare professionals in Canada. Haemophilia 2011; 17: 816-7.
23. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288: 2880-3.
24. Gilbert JR, Evans CE, Haynes RB, Tugwell P. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J 1980; 123: 119-22.
25. Duncan N, Kronenberger W, Roberson C, Shapiro A. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia 2010; 16: 247-55.
26. Foundation N. User friendly Handbook for mixed evaluations. 1997.
27. United Nations Educational, Scientific and Cultural Organization (UNESCO). Revision of the International Standard Classification of Education (ISCED) 2011. Geneva, Switzerland: UNESCO, 2012. Availiable at http://www.uis.unesco.org/Education/Documents/isced-2011-en.pdf. Accessed November 07, 2013.
28. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25: 3186-91.
29. Thornburg CD, Pipe SW. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia. Haemophilia 2006; 12: 198-9.
30. Ware JE Jr. Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 945-52.
31. Bland JM, Altman DG. Cronbach's alpha. BMJ 1997; 314: 572.
32. Lohr K. Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res 2002; 11: 193-205.
33. Streiner D. Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press, 1995.
34. Clark LA, Watson D. Constructing validity: Basic issues in objective scale development. Psychol Assess 1995; 7: 309-19.
35. van der Ende J, Verhulst FC. Informant, gender and age differences in ratings of adolescent problem behaviour. Eur Child Adolesc Psychiatry 2005; 14: 117-26.
36. Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res 2008; 17: 895-913.
37. Gandek B, Ware JE Jr. Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 953-9.
38. du Treil S, Rice J, Leissinger CA. Maintenance of treatment logs by haemophilia patients. Haemophilia 2010; 16: 545-7.
39. Mulders G, de Wee EM, Vahedi Nikbakht-Van de Sande MC, Kruip MJ, Elfrink EJ, Leebeek FW. E-learning improves knowledge and practical skills in haemophilia patients on home treatment: a randomized controlled trial. Haemophilia 2012; 18: 693-8.
40. Remor E. Systematic Review of the Psychometric Properties of the Questionnaire to Evaluate the Adherence to HIV Therapy (CEAT-VIH). Patient 2013; 6: 61-73.
41. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess 2003; 80: 99-103.
42. Wright JG, Young NL. A comparison of different indices of responsiveness. J Clin Epidemiol 1997; 50: 239-46.
43. Lindvall K, Colstrup L, Wollter IM et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia 2006; 12: 47-51.
44. Raat H, Mohangoo AD, Grootenhuis MA. Pediatric health-related quality of life questionnaires in clinical trials. Curr Opin Allergy Clin Immunol 2006; 6: 180-5.
45. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001; 10: 347-57.
46. Addington-Hall J, Kalra L. Who should measure quality of life? BMJ 2001; 322: 1417-20.